201 related articles for article (PubMed ID: 37392208)
1. Predictors of acute ischemic cerebral lesions in immune-mediated thrombotic thrombocytopenic purpura and hemolytic uremic syndrome.
Neuman L; Joseph A; Bouzid R; Lescroart M; Mariotte E; Ederhy S; Tuffet S; Baudel JL; Benhamou Y; Galicier L; Grangé S; Provôt F; Neel A; Pène F; Delmas Y; Presne C; Poullin P; Wynckel A; Perez P; Barbet C; Halimi JM; Chatelet V; Rebibou JM; Ojeda-Uribe M; Vigneau C; Mesnard L; Veyradier A; Azoulay E; Coppo P; Chabriat H;
J Neurol; 2023 Oct; 270(10):5023-5033. PubMed ID: 37392208
[TBL] [Abstract][Full Text] [Related]
2. [Hemolytic and uremic syndrome and related thrombotic microangiopathies: Epidemiology, pathophysiology and clinics].
Rafat C; Coppo P; Fakhouri F; Frémeaux-Bacchi V; Loirat C; Zuber J; Rondeau E
Rev Med Interne; 2017 Dec; 38(12):817-824. PubMed ID: 28711159
[TBL] [Abstract][Full Text] [Related]
3. Thrombotic microangiopathy in malignant hypertension and hemolytic uremic syndrome (HUS)/ thrombotic thrombocytopenic purpura (TTP): can we differentiate one from the other?
Shibagaki Y; Fujita T
Hypertens Res; 2005 Jan; 28(1):89-95. PubMed ID: 15969259
[TBL] [Abstract][Full Text] [Related]
4. Early Differentiation of Shiga Toxin-Associated Hemolytic Uremic Syndrome in Critically Ill Adults With Thrombotic Microangiopathy Syndromes.
Joseph A; Rafat C; Zafrani L; Mariani-Kurkdjian P; Veyradier A; Hertig A; Rondeau E; Mariotte E; Azoulay E
Crit Care Med; 2018 Sep; 46(9):e904-e911. PubMed ID: 29979220
[TBL] [Abstract][Full Text] [Related]
5. Natural history of thrombotic thrombocytopenic purpura and hemolytic uremic syndrome.
Wada H; Matsumoto T; Yamashita Y
Semin Thromb Hemost; 2014 Nov; 40(8):866-73. PubMed ID: 25377323
[TBL] [Abstract][Full Text] [Related]
6. The Oklahoma Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome (TTP-HUS) Registry: a community perspective of patients with clinically diagnosed TTP-HUS.
George JN; Vesely SK; Terrell DR
Semin Hematol; 2004 Jan; 41(1):60-7. PubMed ID: 14727260
[TBL] [Abstract][Full Text] [Related]
7. Thrombotic microangiopathies: thrombotic thrombocytopenic purpura / hemolytic uremic syndrome.
Polito MG; Kirsztajn GM
J Bras Nefrol; 2010; 32(3):303-15. PubMed ID: 21103695
[TBL] [Abstract][Full Text] [Related]
8. A case of hemolytic uremic syndrome caused by Shiga toxin-producing Escherichia coli after pericardiectomy.
Tome J; Maselli DB; Im R; Amdahl MB; Pfeifle D; Hagen C; Halland M
Clin J Gastroenterol; 2022 Feb; 15(1):123-127. PubMed ID: 34677733
[TBL] [Abstract][Full Text] [Related]
9. Atypical reduction of plasma ADAMTS13 activity by a non-IgG-type inhibitor in a patient with hemolytic uremic syndrome caused by Shiga toxin-producing Escherichia coli.
Nakayama S; Hirashio S; Yorishima H; Doi T; Yoshida Y; Matsumoto M; Masaki T
CEN Case Rep; 2019 Nov; 8(4):266-270. PubMed ID: 31177384
[TBL] [Abstract][Full Text] [Related]
10. Does hemolytic uremic syndrome differ from thrombotic thrombocytopenic purpura?
Fakhouri F; Frémeaux-Bacchi V
Nat Clin Pract Nephrol; 2007 Dec; 3(12):679-87. PubMed ID: 18033227
[TBL] [Abstract][Full Text] [Related]
11. The complex differential diagnosis between thrombotic thrombocytopenic purpura and the atypical hemolytic uremic syndrome: Laboratory weapons and their impact on treatment choice and monitoring.
Mannucci PM; Cugno M
Thromb Res; 2015 Nov; 136(5):851-4. PubMed ID: 26386489
[TBL] [Abstract][Full Text] [Related]
12. A pediatric neurologic assessment score may drive the eculizumab-based treatment of Escherichia coli-related hemolytic uremic syndrome with neurological involvement.
Giordano P; Netti GS; Santangelo L; Castellano G; Carbone V; Torres DD; Martino M; Sesta M; Di Cuonzo F; Resta MC; Gaeta A; Milella L; Chironna M; Germinario C; Scavia G; Gesualdo L; Giordano M
Pediatr Nephrol; 2019 Mar; 34(3):517-527. PubMed ID: 30362078
[TBL] [Abstract][Full Text] [Related]
13. Clinical and laboratory patterns of the haemolytic uraemic syndrome and thrombotic thrombocytopenic purpura in southern Iran.
Karimi M; Sabzi A; Peyvandi F; Mannucci PM
Intern Emerg Med; 2006; 1(1):35-9. PubMed ID: 16941811
[TBL] [Abstract][Full Text] [Related]
14. Two novel ADAMTS13 gene mutations in thrombotic thrombocytopenic purpura/hemolytic-uremic syndrome (TTP/HUS).
Licht C; Stapenhorst L; Simon T; Budde U; Schneppenheim R; Hoppe B
Kidney Int; 2004 Sep; 66(3):955-8. PubMed ID: 15327386
[TBL] [Abstract][Full Text] [Related]
15. Neurological manifestations of thrombotic microangiopathy syndromes in adult patients.
Weil EL; Rabinstein AA
J Thromb Thrombolysis; 2021 May; 51(4):1163-1169. PubMed ID: 33755882
[TBL] [Abstract][Full Text] [Related]
16. [Complement-mediated hemolytic uremic syndrome: a diagnostic approach].
Wieliczko M; Twardowska-Kawalec M
Wiad Lek; 2019; 72(11 cz 2):2239-2244. PubMed ID: 31860845
[TBL] [Abstract][Full Text] [Related]
17. Thrombotic Thrombocytopenic Purpura-Haemolytic Uremic Syndrome and pregnancy.
Mwita JC; Vento S; Benti T
Pan Afr Med J; 2014; 17():255. PubMed ID: 25309655
[TBL] [Abstract][Full Text] [Related]
18. [Thrombotic microangiopathies: thrombotic thrombocytopenic purpura (TTP) and hemolytic uremic syndrome (HUS). Morphological features, differential diagnosis, and pathogenesis].
Honsová E
Cesk Patol; 2008 Jul; 44(3):54-8. PubMed ID: 18783134
[TBL] [Abstract][Full Text] [Related]
19. Clinical and Laboratory Consequences of Platelet Transfusion in Shiga Toxin-Mediated Hemolytic Uremic Syndrome.
Beneke J; Sartison A; Kielstein JT; Haller H; Nitschke M; Kunzendorf U; Loos S; Kemper MJ; Stahl RA; Menne J;
Transfus Med Rev; 2017 Jan; 31(1):51-55. PubMed ID: 27468945
[TBL] [Abstract][Full Text] [Related]
20. [Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome (TTP/HUS). Description of a series of 35 patients].
Martínez Francés A; Pereira A; Ordinas A
Med Clin (Barc); 1997 Jun; 109(2):49-52. PubMed ID: 9280801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
